Resolution of the consensus of Russian Federation experts on the diagnosis and treatment of osteoarthritis for primary care physicians


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

EXPERTS: ALEKSEEVA L.I., MD, professor, head of the Department of metabolic diseases of bones and joints, V.A. Nasonova Scientific Research Institute of Rheumatology, professor of the Department of rheumatology, Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of Russia (Moscow) BARANTSEVICH E.R., MD, professor, head of the Department of neurology and manual medicine, Academician I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of Russia, chief neurologist of the Northwestern Federal District of the RF, member of the board of experts of the Association for Interdisciplinary Medicine (Saint Petersburg) VASILKIN A.K., PhD in Medicine, deputy chief physician for medical rehabilitation, R.R. Vreden National Medical Research Centre of Traumatology and Orthopedics of the Ministry of Healthcare of Russia (Saint Petersburg) GAYDUKOVA I.Z., MD, deputy director of the Research Institute of Rheumatology, professor of the Department of therapy, rheumatology, examination of temporary disability and quality of medical care named after E.E. Eichwald, 1.1. Mechnikov North-Western State Medical University of the Ministry of Healthcare of Russia (Saint Petersburg) KARATEEV A.E., MD, head of the Department of inflammatory joint pathology, V.A. Nasonova Research Institute of Rheumatology (Moscow) KOCHISH A.Yu., MD, professor, deputy director for scientific and educational work, R.R. Vreden National Medical Research Centre of Traumatology and Orthopedics of the Ministry of Healthcare of Russia (Saint Petersburg) LILA A.M., MD, professor, corresponding member of RAS, director of V.A. Nasonova Scientific Research 120 Institute of Rheumatology, head of the Department of rheumatology, Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of Russia (Moscow) MAZUROV V.I., MD, professor, academician of RAS, chief scientific consultant, director of the Research Institute of Rheumatology, head of the Department of therapy, rheumatology, examination of temporary disability and quality of medical care named after E.E. Eichwald, I.I. Mechnikov North-Western State Medical University of the Ministry of Healthcare of Russia, chief freelance specialist rheumatologist of the Health Committee of the Government of Saint Petersburg, Honored Scientist of the Russian Federation (Saint Petersburg) MARTYNOV A.I., MD, professor, academician of RAS, head of the Department of internal diseases No. 1 of the Faculty of general medicine, A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia, president of RSMSIM (Moscow) TASKINA E.A., PhD in Medicine, senior researcher at the Department of metabolic diseases of bones and joints, V.A. Nasonova Scientific Research Institute of Rheumatology (Moscow) TROFIMOV E.A., MD, deputy director of the Research Institute of Rheumatology, associate professor of the Department of therapy, rheumatology, examination of temporary disability and quality of medical care named after E.E. Eichwald, I.I. Mechnikov North-Western State Medical University of the Ministry of Healthcare of Russia (Saint Petersburg) CHICHASOVA N.V., MD, professor, leading researcher at V.A. Nasonova Scientific Research Institute of Rheumatology, professor of the Department of rheumatology, Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of Russia (Moscow) SHOSTAK N.A., MD, professor, Honored Doctor of the Russian Federation, head of the Department of faculty therapy named after A.I. Nesterov, N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia (Moscow)

全文:

受限制的访问

作者简介

- -

参考

  1. Балабанова Р.М., Дубинина Т.В. Динамика пятилетней заболеваемости болезнями костно-мышечной системы и их распространенности среди взрослого населения России за 2013-2017 гг. Современная ревматология. 2019; 4: 11-17. @@Balabanova R.M., Dubinina T.V Fiveyear (2013-2017) trends in the incidence and prevalence of musculoskeletal system diseases among the adult population of Russia. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2019; 4: 11-17. (In Russ.)]. http://dx.doi.org/10.14412/1996-7012-2019-4-11-17.
  2. Галушко Е.А., Большакова Т.В., Виноградова И.Б. с соавт. Структура ревматических заболеваний среди взрослого населения России по данным эпидемиологического исследования (предварительные результаты). Научно-практическая ревматология. 2009; 1: 11-17. @@Galushko E.A., Bolshakova T.V., Vinogradova I.B. et al. Structure of rheumatic diseases among adult population of russia according to data of an epidemiological study (preliminary results). Nauchno-prakticheskaya revmatologiya = Scientific and Practical Rheumatology. 2009; 1: 11-17 (In Russ.)
  3. Global Burden of Disease Collaborative Network. Global burden of disease study 2019 (GBD 2019) results. 2020. URL: http://ghdx.healthdata.org/gbdresults-tool (date of access - 02.11.2020).
  4. Constantino de Campos G., Mundi R., Whittington C. et al. Osteoarthritis, mobility-related comorbidities and mortality: An overview of meta-analyses. Ther Adv Musculoskelet Dis. 2020; 12: 1759720X20981219. http://dx.doi.org/10.1177/1759720X20981219.
  5. Алексеева Л.И., Таскина Е.А., Кашеварова Н.Г Остеоартрит: эпидемиология, классификация, факторы риска и прогрессирования, клиника, диагностика, лечение. Современная ревматология. 2019; 2: 9-21. @@Alekseeva L.I., Taskina E.A., Kashevarova N.G. Osteoarthritis: epidemiology, classification, risk factors, and progression, clinical presentation, diagnosis, and treatment. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2019; 2: 9-21 (In Russ.)]. http://dx.doi.org/10.14412/1996-7012-2019-2-9-21.
  6. Coimbra I.B., Plapler P.G., de Campos G.C. Generating evidence and understanding the treatment of osteoarthritis in Brazil: A study through Delphi methodology. Clinics (Sao Paulo). 2019; 74: e722. http://dx.doi.org/10.6061/clinics/2019/e722.
  7. Martel-Pelletier J., Maheu E., Pelletier J.P. et al. A new decision tree for diagnosis of osteoarthritis in primary care: international consensus of experts. Aging Clin Exp Res. 2019; 31(1): 19-30. http://dx.doi.org/10.1007/s40520-018-1077-8.
  8. Bruyere O., Honvo G., Veronese N. et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019; 49(3): 337-50. http://dx.doi.org/10.1016/j.semarthrit.2019.04.008.
  9. А.М. Лила, Л.И. Алексеева, Е.А. Таскина, Н.Г Кашеварова. Современный алгоритм лечения остеоартрита. Терапия. 2022; 2: 65-76. @@Lila A.M., Alekseeva L.I., Taskina E.A., Kashevarova N.G. Modern algorithm for the treatment of osteoarthritis. Terapiya = Therapy. 2022; 2: 65-76 (In Russ.)]. https://dx.doi.org/10.18565/therapy.2022.2.65-76.
  10. Salis Z., Sainsbury A., I Keen H. et al. Weight loss is associated with reduced risk of knee and hip replacement: A survival analysis using Osteoarthritis Initiative data.Int J Obes (Lond). 2022. http://dx.doi.org/10.1038/s41366-02101046-3. Online ahead of print.
  11. Wolff D.G., Christophersen C., Brown S.M., Mulcahey M.K. Topical nonsteroidal anti-inflammatory drugs in the treatment of knee osteoarthritis: A systematic review and meta-analysis. Phys Sportsmed. 2021; 49(4): 381-91. https://dx.doi.org/10.1080/00913847.2021.1886573.
  12. Da Costa B.R., Reichenbach S., Keller N. et al. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: A network meta-analysis. Lancet. 2017; 390(10090): e21-e33. https://dx.doi.org/10.1016/S0140-6736(17)31744-0.
  13. Conaghan P.G., Arden N., Avouac B. et al. Safety of paracetamol in osteoarthritis: What does the literature say? Drugs Aging. 2019; 36(Suppl 1): 7-14. https://dx.doi.org/10.1007/s40266-019-00658-9.
  14. Leopoldino A.O., Machado G.C., Ferreira P.H. et al. Paracetamol versus placebo for knee and hip osteoarthritis. Cochrane Database Syst. Rev. 2019; 2: CD013273. https://dx.doi.org/10.1002/14651858.CD013273.
  15. Таскина Е.А., Кашеварова Н.Г, Алексеева Л.И. Место нестероидных противовоспалительных препаратов в современных рекомендациях по остеоартриту. Современная ревматология. 2020; 2: 123-130. @@Taskina E.A., Kashevarova N.G., Alekseeva L.I. The place of nonsteroidal anti-inflammatory drugs in the current osteoarthritis guidelines. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2020; 2: 123-130 (In Russ.)]. https://dx.doi.org/10.14412/1996-7012-2020-2-123-130.
  16. Osani M.C., Vaysbrot E.E., Zhou M. et al. Duration of symptom relief and early trajectory of adverse events for oral nonsteroidal antiinflammatory drugs in knee osteoarthritis: A systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2020; 72(5): 641-51. https://dx.doi.org/10.1002/acr.23884.
  17. Каратеев А.Е., Насонов Е.Л., Ивашкин В.Т. с соавт. Рациональное использование нестероидных противовоспалительных препаратов. Клинические рекомендации. Научно-практическая ревматология. 2018; S1: 1-29. @@Karateev A.E., Nasonov E.L., Ivashkin V.T. et al. Rational use of nonsteroidal anti-inflammatory drugs. Clinical guidelines. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2018; S1: 1-29 (In Russ.)]. https://dx.doi.org/10.14412/1995-4484-2018-1-29

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2022
##common.cookie##